Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,43 USD | +2,93% | +3,18% | +6,98% |
27/03 | Outlook Therapeutics-aandelen stijgen na BTIG-upgrade | MT |
27/03 | OUTLOOK THERAPEUTICS, INC. : BTIG verhoogt advies naar kopen | ZM |
Omzet 2024 * | 204K 191K | Omzet 2025 * | 11,85 mln. 11,09 mln. | Marktkapitalisatie | 196 mln. 184 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -72 mln. -67,34 mln. | Nettowinst (verlies) 2025 * | -62 mln. -57,99 mln. | EV/omzet 2024 * | 964 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 16,6 x |
K/w-verhouding 2024 * |
-2,53
x | K/w-verhouding 2025 * |
-3,62
x | Werknemers | 24 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 61,15% |
Recentste transcriptie over Outlook Therapeutics, Inc.
1 dag | +2,93% | ||
1 week | +3,18% | ||
Lopende maand | -29,40% | ||
1 maand | -2,88% | ||
3 maanden | -2,43% | ||
6 maanden | -21,07% | ||
Lopend jaar | +6,98% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 07-07-21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15-09-15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 13-04-18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 11-12-15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 07-07-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 9 M€ | +6,26% | - | |
0.00% | 147 M€ | +4,88% | - | |
0.00% | 18 M€ | +3,86% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 8,43 | +2,93% | 120 913 |
25-04-24 | 8,19 | -0,12% | 150 771 |
24-04-24 | 8,2 | 0,00% | 339 980 |
23-04-24 | 8,2 | +1,36% | 151 657 |
22-04-24 | 8,09 | -0,98% | 210 765 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,98% | 188 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |